In vitro effects of 2-methoxyestradiol on cell numbers, morphology, cell cycle progression, and apoptosis induction in oesophagealcarcinoma cells

Cell Biochemistry and Function

Volumn 27, Issue 4, 2009, Pages 205-210

  Thaver, Vaneesha ^a,b   Lottering, Mona Liza ^b   van Papendorp, Dirk ^b   Joubert, Annie ^b  

^a UNIVERSITY OF LIMPOPO   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

2 methoxyestradiol; Apoptosis; Metaphase block; Oesophageal carcinoma

Indexed keywords

2 METHOXYESTRADIOL; BETA TUBULIN; CYCLIN DEPENDENT KINASE 1; DEATH RECEPTOR 5;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL DISRUPTION; CELL STRUCTURE; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ESOPHAGUS CARCINOMA; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ANTIMITOTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL COUNT; CELL CYCLE; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGEAL NEOPLASMS; ESTRADIOL; HUMANS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUBULIN; TUMOR CELLS, CULTURED;

EID: 68249141247     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1557     Document Type: Article

References (32)

1. Dingli D, Timm M, Russell SJ, Witzig TE, Rajkumar SV. Promising preclinical activity of 2-methoxyestradiol in multiple myeloma. Clin Cancer Res 2002; 8: 3948-3954.
2. Lottering ML, Haag M, Seegers JC. Effects of 17 beta-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res 1992; 52: 5926-5932.
3. Lis A, Ciesielski MJ, Barone TA, Scott BE, Fenstermaker RA, Plunkett RJ. 2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro. Cancer Lett 2004; 213: 57-65.
4. D'Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 1994; 91: 3964-3968.
5. Mooberry SL. Mechanism of action of 2-methoxyestradiol: new developments. Drug Resist Updat 2003; 6: 355-361.
6. Wang SH, Myc A, Koenig RJ, Bretz JD, Arscott PL, Baker JR. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces thyroid cell apoptosis. Mol Cell Endocrinol 2000; 165: 163-172.
7. Nakagawa-Yagi Y, Ogane N, Inoki Y, Kitoh N. The endogenous estrogen metabolite 2-methoxyestradiol induces apoptotic neuronal cell death in vitro. Life Sci 1996; 58: 1461-1467.
8. Joubert A, Maritz C, Joubert F. Bax/Bcl-2 expression levels of 2-methoxyestradiol-exposed esophageal cancer cells. Biomed Res 2005; 26: 131-134.
9. Joubert A, Maritz C, Joubert F. Influence of prostaglandin A2 and 2-methoxyestradiol on Bax and Bcl-2 expression levels in cervical carcinoma cells. Biomed Res 2005; 26: 87-90.
10. Joubert A, Marais S. Influence of 2-methoxyestradiol on cell morphology and cdc2 kinase activity in WHCO3 esophageal carcinoma cells. Biomed Res 2007; 28: 9-16.
11. Van ZC Lottering, Steffens ML, Joubert FA. In vitro effects of 2-methoxyestradiol on MCF-12A and MCF-7 cell growth, morphology and mitotic spindle formation. Cell Biochem Funct 2008; 26: 632-642.
12. Andreassen PR, Margolis RL. Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells. J Cell Biol 1994; 127: 789-802.
13. LaVallee TM, Zhan XH, Johnson MS, et al. 2-methoxyestradiol upregulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway. Cancer Res 2003; 63: 468-475.
14. Qanungo S, Basu A, Das M, Haldar S. 2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells. Oncogene 2002; 21: 4149-4157.
15. Thaver V. Mechanism(s) of apoptosis induction by 2-methoxyestradiol, an estrogen metabolite, in SNO and WHCO3 oesophageal carcinoma cell lines. University of Pretoria. 2003.
16. Pribluda VS, Gubish ER Jr, LaVallee TM, Treston A, Swartz GM, Green SJ. 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev 2000; 19: 173-179.
17. Banerjee SK, Zoubine MN, Sarkar DK, Weston AP, Shah JH, Campbell DR. 2-Methoxyestradiol blocks estrogen-induced rat pituitary tumor growth and tumor angiogenesis: possible role of vascular endothelial growth factor. Anticancer Res 2000; 20: 2641-2645.
18. Lippert TH, Adlercreutz H, Berger MR, Seeger H, ElgerW, Mueck AO. Effect of 2-methoxyestradiol on the growth of methyl-nitroso-urea (MNU)-induced rat mammary carcinoma. J Steroid Biochem Mol Biol 2003; 84: 51-56.
19. Lakhani NJ, Sarkar MA, Venitz J, Figg WD. 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 2003; 23: 165-172.
20. Basu A, Castle VP, Bouziane M, Bhalla K, Haldar S. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family. Cancer Res 2006; 66: 4309-4318.
21. Golab J, Nowis D, Skrzycki M, et al. Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor. J Biol Chem 2003; 278: 407-414.
22. Fotsis T, Zhang Y, Pepper MS, et al. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 1994; 368: 237-239.
23. Seegers JC, Aveling ML, Van Aswegen CH, Cross M, Koch F, Joubert WS. The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. J Steroid Biochem 1989; 32: 797-809.
24. Maran A, Zhang M, Kennedy AM, et al. 2-methoxyestradiol induces interferon gene expression and apoptosis in osteosarcoma cells. Bone 2002; 30: 393-398.
25. Gillies RJ, Didier N, Denton M. Determination of cell number in monolayer cultures. Anal Biochem 1986; 159: 109-113.
26. Ciancio G, Pollack A, Taupier MA, Block NL, Irvin GL III. Measurement of cell-cycle phase-specific cell death using Hoechst 33342 and propidium iodide: preservation by ethanol fixation. J Histochem Cytochem 1988; 36: 1147-1152.
27. Huppertz B, Frank HG, Kaufmann P. The apoptosis cascade-morphological and immunohistochemical methods for its visualization. Anat Embryol (Berl) 1999; 200: 1-18.
28. Amant F, Lottering ML, Joubert A, Thaver V, Vergote I, Lindeque BG. 2-Methoxyestradiol strongly inhibits human uterine sarcomatous cell growth. Gynecol Oncol 2003; 91: 299-308.
29. Perez-Stable C. 2-Methoxyestradiol and paclitaxel have similar effects on the cell cycle and induction of apoptosis in prostate cancer cells. Cancer Lett 2006; 231: 49-64.
30. Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 2000; 45: 528-537.
31. Burns TF, El-Deiry WS. The p53 pathway and apoptosis. J Cell Physiol 1999; 181: 231-239.
32. Ibrahim SM, Ringel J, Schmidt C, et al. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death. Pancreas 2001; 23: 72-79.